✦ LIBER ✦

Structure-Based Drug Design of RN486, a Potent and Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis

✍ Scribed by Lou, Yan; Han, Xiaochun; Kuglstatter, Andreas; Kondru, Rama K.; Sweeney, Zachary K.; Soth, Michael; McIntosh, Joel; Litman, Renee; Suh, Judy; Kocer, Buelent; Davis, Dana; Park, Jaehyeon; Frauchiger, Sandra; Dewdney, Nolan; Zecic, Hasim; Taygerly, Joshua P.; Sarma, Keshab; Hong, Junbae; Hill, Ronald J.; Gabriel, Tobias; Goldstein, David M.; Owens, Timothy D.

Book ID: 123616681
Publisher: American Chemical Society
Year: 2014
Tongue: English
Weight: 426 KB
Volume: 58
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm500305p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structure-Based Design of a Potent, Sele

Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases

✍ Singh, Juswinder; Dobrusin, Ellen M.; Fry, David W.; Haske, Taraneh; Whitty, Adr 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 209 KB

PRO_SELECT: Combining Structure-Based Dr

PRO_SELECT: Combining Structure-Based Drug Design and Array-Based Chemistry for Rapid Lead Discovery. 2. The Development of a Series of Highly Potent and Selective Factor Xa Inhibitors

✍ Liebeschuetz, John W.; Jones, Stuart D.; Morgan, Phillip J.; Murray, Chris W.; R 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 318 KB

Structure-based design of nitrogen-linke

Structure-based design of nitrogen-linked macrocyclic kinase inhibitors leading to the clinical candidate SB1317/TG02, a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3)

✍ Anders Poulsen, Anthony William, Stéphanie Blanchard, Harish Nagaraj, Meredith W 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 704 KB